A Controlled Trial of Renal Denervation for Resistant HypertensionDeepak L. Bhatt, George L. Bakris, David E. Kandzari et al.|New England Journal of Medicine|2014Cited by 2.2k
Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 studyHenry Krum, Murray Esler, Markus P. Schlaich et al.|The Lancet|2013Cited by 622
Predictors of blood pressure response in the SYMPLICITY HTN-3 trialDavid E. Kandzari, George L. Bakris, Murray Esler et al.|European Heart Journal|2014Cited by 540
Catheter‐Based Renal Denervation for Resistant Hypertension: Rationale and Design of the SYMPLICITY HTN‐3 TrialDavid E. Kandzari, George L. Bakris, Deepak L. Bhatt et al.|Clinical Cardiology|2012Cited by 309
Excimer laser with adjunctive balloon angioplasty and heparin‐coated self‐expanding stent grafts for the treatment of femoropopliteal artery in‐stent restenosisJohn R. Laird, Michael R. Jaff, Khung Keong Yeo et al.|Catheterization and Cardiovascular Interventions|2012Cited by 72